STOCK TITAN

Saira Ramasastry to sell 2,000 shares via option exercise (NASDAQ: MIRM)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Saira Ramasastry reported a proposed sale of Common Stock. The notice covers 2,000 shares to be sold on 03/16/2026 pursuant to a stock option exercise for cash, listed as "ISSUER" in the filing.

The filing also lists recent dispositions by the same holder: 2,000 shares on 02/13/2026 for $204,180.00, 2,000 shares on 01/15/2026 for $181,980.00, 5,000 shares on 12/22/2025 for $400,000.00, and 2,000 shares on 12/18/2025 for $139,460.00.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 reports a small option-exercise sale by an individual holder.

The filing documents a 2,000-share proposed sale on 03/16/2026 via stock option exercise, with cash proceeds and the method labeled "ISSUER." This is a customary disclosure of a planned disposition under Section 144 rules.

The excerpt lists multiple recent sales by the same holder in the prior months, shown with dates and dollar amounts. These prior transactions provide context about recent liquidity activity but do not, by themselves, indicate material company-level impact.

Disclosure follows regulatory notice requirements; no conditional approvals are stated.

The notice names the selling holder and the broker and specifies the sale method as an option exercise leading to cash proceeds to the issuer. The filing attaches precise share counts and transaction dates for prior dispositions.

Because this is a holder-level resale notice, the filing is administrative in nature; cash-flow treatment and any lock-up or holder restrictions are not described in the provided excerpt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filed for MIRM show?

The Form 144 notifies a proposed sale of 2,000 shares of Common Stock via a stock option exercise scheduled for 03/16/2026. It lists the broker as Morgan Stanley Smith Barney LLC and identifies cash proceeds to the issuer.

Who is the selling holder named in the MIRM Form 144?

The selling holder is listed as Saira Ramasastry with a Foster City address. The filing names a broker, Morgan Stanley Smith Barney LLC, and records the method as a stock option exercise for cash to the issuer.

How many recent share dispositions by this holder are shown in the filing?

The excerpt shows four prior dispositions in the past months: 2,000 shares on 02/13/2026, 2,000 shares on 01/15/2026, 5,000 shares on 12/22/2025, and 2,000 shares on 12/18/2025, each with reported dollar amounts.

Does the Form 144 state how proceeds will be used?

The filing indicates the transaction method as a stock option exercise and records cash treatment; it does not provide any use-of-proceeds details or further allocation information in the provided excerpt.

Does this Form 144 filing indicate material company-level impact for MIRM?

This is a holder-level notice of a proposed sale and lists modest share counts and recent dispositions. The filing is routine administrative disclosure and does not, by itself, indicate a material company-level event.
Mirum Pharmaceuticals

NASDAQ:MIRM

View MIRM Stock Overview

MIRM Rankings

MIRM Latest News

MIRM Latest SEC Filings

MIRM Stock Data

5.47B
51.10M
Biotechnology
Pharmaceutical Preparations
Link
United States
FOSTER CITY